Peanut allergy associated with vaccinations leads to profit for patch-peddling pharmaceutical company

(NaturalNews) A French pharmaceutical company is hoping to reap massive profits from a new drug patch that it says treats a common food allergy caused by vaccines. The DBV Technologies SA Viaskin Peanut patch for peanut allergy currently holds a market value of $1 billion, according...

from NaturalNews.com http://ift.tt/1U1lGZv